Last update 15 Jul 2025

ATI-9242

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ATI 9242
Target
5-HT1A receptor x 5-HT2A receptor x 5-HT7 receptor x D2 receptor
Action
agonists, antagonists, modulators
Mechanism
5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), 5-HT7 receptor modulators(Serotonin 7 (5-HT7) receptor modulators)
Therapeutic Areas
Nervous System Diseases
Active Indication
Schizophrenia
Inactive Indication-
Originator Organization
ARYx Therapeutics, Inc.ARYx Therapeutics, Inc.
Active Organization
ARYx Therapeutics, Inc.ARYx Therapeutics, Inc.
Inactive Organization
Braeburn, Inc.Braeburn, Inc.Cascadian Therapeutics LLCCascadian Therapeutics LLC
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ATI-9242
NCT02824666
/ CompletedPhase 1
Phase 1, Open-Label Positron Emission Tomography (PET) Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 in Adult Male Healthy Subjects
100 Clinical Results associated with ATI-9242
Login to view more data
100 Translational Medicine associated with ATI-9242
Login to view more data
100 Patents (Medical) associated with ATI-9242
Login to view more data
100 Deals associated with ATI-9242
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPhase 1
United States
Braeburn, Inc.Braeburn, Inc.
20 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free